Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2018

01-10-2018 | Original Article

Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis

Authors: Ozlem Unay Demirel, Seyda Ignak, Mustafa Cagatay Buyukuysal

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2018

Login to get access

Abstract

The efficiency of plateletpheresis was improved owing to new developments in automated cell separators in the past decades. Nowadays multiple units of plateletpheresis products can be taken per collection from single donor and new parameters such as immature platelet fraction (IPF), immature platelet count (IPC) can be detected practically by automated hematology analyzers. Our aim is to find out a new quality parameter for evaluation of plateletpheresis by analyzing the platelet indices of donor and also to predict platelet recovery in recipients thereby preventing unnecessary platelet transfusion. In this study 104 platelet apheresis procedures were performed on the Trima Accel cell separator. Complete blood counts of donors and recipients were analyzed by Sysmex XN-1000 automated blood cell counter by means of quality parameters such as platelet count, IPF, IPC, mean platelet volume, platelet distribution width. We analyzed these parameters in the follow up after the transfusion of plateletpheresis and evaluated them as quality markers in the assessment of plateletpheresis effectiveness. For recipients of both single and double unit apheresis platelet transfusions, the pre-apheresis donor IPC correlated significantly with 1st and 24th hour recipient IPC values (p values < 0.05 for all comparisons). A-IPC as well as % change in IPF can be used to determine the quality of plateletpheresis in conjunction with platelet number in terms of evaluation of donors and also in the follow up of recipients undergoing platelet transfusion.
Literature
1.
go back to reference McLeod BC (2010) Therapeutic apheresis: history, clinical application, and lingering uncertainties. Transfusion 50:1413–1426CrossRefPubMed McLeod BC (2010) Therapeutic apheresis: history, clinical application, and lingering uncertainties. Transfusion 50:1413–1426CrossRefPubMed
2.
go back to reference Holbro A, Infanti L, Sigle J, Buser A (2013) Platelet transfusion: basic aspects. Swiss Med Wkly 143:w13885PubMed Holbro A, Infanti L, Sigle J, Buser A (2013) Platelet transfusion: basic aspects. Swiss Med Wkly 143:w13885PubMed
5.
go back to reference Moog R (2009) Feasibility and safety of triple dose platelet collection by apheresis. J Clin Apher 24:238–240CrossRefPubMed Moog R (2009) Feasibility and safety of triple dose platelet collection by apheresis. J Clin Apher 24:238–240CrossRefPubMed
7.
go back to reference Bilgin AU, Karadogan I, Yilmaz FG, Undar L (2007) Double dose plateletpheresis by continuous and intermittent flow devices increases platelet-neutrophil complex formation in healthy donors without noticeable neutrophil activation. Transfus Apher Sci 36:31–37CrossRefPubMed Bilgin AU, Karadogan I, Yilmaz FG, Undar L (2007) Double dose plateletpheresis by continuous and intermittent flow devices increases platelet-neutrophil complex formation in healthy donors without noticeable neutrophil activation. Transfus Apher Sci 36:31–37CrossRefPubMed
8.
go back to reference Vinholt PJ, Hvas AM, Nybo M (2014) An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients. Eur J Haematol 92:367–376CrossRefPubMed Vinholt PJ, Hvas AM, Nybo M (2014) An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients. Eur J Haematol 92:367–376CrossRefPubMed
9.
go back to reference Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE (2013) Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion 53:1201–1204CrossRefPubMed Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE (2013) Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion 53:1201–1204CrossRefPubMed
10.
go back to reference Hoffmann JJ (2014) Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 52:1107–1117CrossRefPubMed Hoffmann JJ (2014) Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 52:1107–1117CrossRefPubMed
11.
go back to reference Dusse LM, Freitas LG (2015) Clinical applicability of reticulated platelets. Clin Chim Acta 439:143–147CrossRefPubMed Dusse LM, Freitas LG (2015) Clinical applicability of reticulated platelets. Clin Chim Acta 439:143–147CrossRefPubMed
12.
go back to reference Briggs C, Kunka S, Hart D, Oguni S, Machin SJ (2004) Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 126:93–99CrossRefPubMed Briggs C, Kunka S, Hart D, Oguni S, Machin SJ (2004) Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 126:93–99CrossRefPubMed
13.
go back to reference (2003) Standards for blood banks and transfusion services, 22nd edn. American Association of Blood Banks, Bethesda, pp 11–69 (2003) Standards for blood banks and transfusion services, 22nd edn. American Association of Blood Banks, Bethesda, pp 11–69
14.
go back to reference (2005) Guide to the preparation use and quality assurance of blood components, 11th edn. Council of Europe Press, Strasbourg, pp 31–59 (2005) Guide to the preparation use and quality assurance of blood components, 11th edn. Council of Europe Press, Strasbourg, pp 31–59
15.
go back to reference (2009) National blood and blood products guide. The Ministry of Health of Turkey, Ankara, pp 224–225 (2009) National blood and blood products guide. The Ministry of Health of Turkey, Ankara, pp 224–225
16.
go back to reference Arslan O (2007) Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med 17:379–383CrossRefPubMed Arslan O (2007) Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med 17:379–383CrossRefPubMed
17.
go back to reference Elkins M, Davenport R, Mintz PD (2017) Transfusion medicine. In: McPherson RA, Pincus MR (eds) Henry’s clinical diagnosis and management by laboratory methods, 23rd edn. Elsevier, St. Louis, pp 735–750 Elkins M, Davenport R, Mintz PD (2017) Transfusion medicine. In: McPherson RA, Pincus MR (eds) Henry’s clinical diagnosis and management by laboratory methods, 23rd edn. Elsevier, St. Louis, pp 735–750
18.
go back to reference Sachdeva P, Kaur G, Basu S, Tahlan A (2014) Assessment of factors affecting the platelet yield using continuous flow cell separator. Int J Biomed Res 5:196–199CrossRef Sachdeva P, Kaur G, Basu S, Tahlan A (2014) Assessment of factors affecting the platelet yield using continuous flow cell separator. Int J Biomed Res 5:196–199CrossRef
19.
go back to reference Guerrero-Rivera S, Gutiérrez-Espíndola G, Talavera JO, Meillón-García LA, Pedraza-Echevarría M, Pizzuto-Chávez J (2003) Hemoglobin and platelet count effect on platelet yields in plateletpheresis. Arch Med Res 34:120–123CrossRefPubMed Guerrero-Rivera S, Gutiérrez-Espíndola G, Talavera JO, Meillón-García LA, Pedraza-Echevarría M, Pizzuto-Chávez J (2003) Hemoglobin and platelet count effect on platelet yields in plateletpheresis. Arch Med Res 34:120–123CrossRefPubMed
20.
go back to reference Picker SM, Radojska SM, Gathof BS (2006) Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Transfusion 46:1601–1608CrossRefPubMed Picker SM, Radojska SM, Gathof BS (2006) Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Transfusion 46:1601–1608CrossRefPubMed
22.
go back to reference Strauss RG (1995) Clinical perspectives of platelet transfusions: defining the optimal dose. J Clin Apher 10:124–127CrossRefPubMed Strauss RG (1995) Clinical perspectives of platelet transfusions: defining the optimal dose. J Clin Apher 10:124–127CrossRefPubMed
23.
go back to reference Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, Villarica GO, Ruisi MM, Gernsheimer TB, Beer JH, Bussel JB (2011) Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 117:5723–5732CrossRefPubMedPubMedCentral Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, Villarica GO, Ruisi MM, Gernsheimer TB, Beer JH, Bussel JB (2011) Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 117:5723–5732CrossRefPubMedPubMedCentral
24.
go back to reference Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, Onishi K, Nakatani K, Morishita Y, Oguni S, Nobori T (2006) A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 118:463–469CrossRefPubMed Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, Onishi K, Nakatani K, Morishita Y, Oguni S, Nobori T (2006) A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 118:463–469CrossRefPubMed
25.
go back to reference Jung H, Jeon HK, Kim HJ, Kim SH (2010) Immature platelet fraction: establishment of a reference interval and diagnostic measure for thrombocytopenia. Korean J Lab Med 30:451–459CrossRefPubMed Jung H, Jeon HK, Kim HJ, Kim SH (2010) Immature platelet fraction: establishment of a reference interval and diagnostic measure for thrombocytopenia. Korean J Lab Med 30:451–459CrossRefPubMed
26.
go back to reference Dadu T, Sehgal K, Joshi M, Khodaiji S (2014) Evaluation of the immature platelet fraction as an indicator of platelet recovery in dengue patients. Int J Lab Hematol 36:499–504CrossRefPubMed Dadu T, Sehgal K, Joshi M, Khodaiji S (2014) Evaluation of the immature platelet fraction as an indicator of platelet recovery in dengue patients. Int J Lab Hematol 36:499–504CrossRefPubMed
27.
go back to reference Vaughan J, Wiggill T, Munster M (2014) Immature platelet fraction levels in a variety of bone marrow pathologies in South African HIV-positive patients with thrombocytopenia. Hematology 19:417–423CrossRefPubMed Vaughan J, Wiggill T, Munster M (2014) Immature platelet fraction levels in a variety of bone marrow pathologies in South African HIV-positive patients with thrombocytopenia. Hematology 19:417–423CrossRefPubMed
Metadata
Title
Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis
Authors
Ozlem Unay Demirel
Seyda Ignak
Mustafa Cagatay Buyukuysal
Publication date
01-10-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0965-6

Other articles of this Issue 4/2018

Indian Journal of Hematology and Blood Transfusion 4/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine